Effects of Leucaena leucocephala (Lam.) de Wit Leaves Extracts in Culture of Human Umbilical Vein Cells

Chatchanayuenyong, Sujayanont, and Vuttivirojana: Effects of Leucaena leucocephala (Lam.) de Wit Leaves Extracts in Culture of Human Umbilical Vein Cells

Authors

INTRODUCTION

Impaired fasting glucose (IFG) is a type of prediabetes that found in those with increasing of fasting blood glucose but not yet develop diabetes mellitus.1 Several studies have suggested that rising of blood glucose can be induced by the elevation of oxidative stress, through the production of reactive oxygen species (ROS) that influence insulin resistance and eventually result in beta-cell dysfunction and diabetes mellitus.2,3 The ROS are also initiate a chain reaction, and result in reduction of nitric oxide (NO) availability and presentation of several inflammation markers. Altogether, these events lead to dysfunction of endothelial cell and development of cardiovascular disease.4

Cardiovascular diseases (CVS) contribute to most noncommunicable diseases (NCDs) with 17.5 million in year 2012, and was predicted to increase to 592 million in year 2035.5 It is known that an impairment of NO production6,7 and scavenger enzyme such as superoxide dismutase (SOD) can be resulting in oxidative stress.8 This event is eventually leading to endothelial dysfunction, and tissue injury of vascular cells. Endothelial dysfunction can be found in patients with diabetes,2,9,10 hyperlipidemia, and atherosclerosis and hypertension.10,11 Other than NO and SOD, the reported potential biomarkers of endothelial dysfunctions is oxidized low-density lipoprotein (oxLDL), as well as malondialdehyde (MDA) that have been expressed in vascular diseases.12,13,14 Several Thai traditional herbal medicines have been suggested as providing antioxidant activities, and one of them are Leucaena leucocephala (Lam) de Wit.

L. leucocephala has been reported of processing antioxidant activities by providing important substances such as flavonoids, terpenes and coumarins, sterols.15 It has been reported for lowering blood glucose, blood pressure and NO level, and providing hypochlolesteromic, anti-inflammatory and antioxidant activity.16,17,18 In previous studies, glucose and LDL can induce endothelial dysfunction of the vessels in diabetic and cardiovascular patients.9,19,20 Thus, optimal level of L. leucocephala may protect vascular cell through reduction of LDL and glucose oxidation. Altogether, it leads to objective of the study, to observe antioxidant activity of L. leucocephala in endothelium function using impair fasting glucose in human umbilical vein cultured (HUVCs) model.

MATERIAL AND METHOD

Extracts preparation

Fresh leaves of L. leucocephala were collected from Sakolnakorn province, Thailand. Leaves were dried at 60°C and then immersed in 90% ethanol for 3 days. The solution was evaporated using rotary evaporator (BossTech, Scientific Instruments) followed by lyophilization. Prior to the experiment, leave extract preparing in 50% ethanol was filtrated by membrane filter (0.45 μm-pore size) and diluted to different concentrations (0.05, 0.1, 0.5 and 1 mg/ml).

Determination of antioxidant contents

The antioxidant properties of total phenolic content (TPC) are potential for inhibiting lipid peroxidation. TPC concentration was estimated with Folin-Ciocalteu reagent using gallic acid as standard, described previously.21 Briefly, 10% Folin-Ciocalteu reagent and 10.75% Na2CO3 were mixed with L. leucocephala. TPC product was measured at 760 nm spectrophotometrically and was calculated from standard curve of gallic acid and expressed as mg GAE/g of sample dried weight.

Total flavonoid content (TFC) was determined by the aluminum chloride colorimetric method according to Zhishen J et al.22 L. leucocephala was incubated in 5% NaNO2 at room temperature for 5 min, and followed by 10% AlCl3 for 5 min and 1M NaOH. The mixture was incubated at room temperature for 15 min and measured absorbance at 510 nm with UV-spectrophotometer. TFC was calculated from standard curve as catechin and expressed as mg of catechin/g of sample dry weight.

Antioxidant activity
1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity

DPPH assay was performed to measure scavenging activity.23 Briefly, leave extracts were dissolved in 0.5 nM DPPH to final concentration as following, 6.125 μg/ml, 12.5 μg/ml, 25 μg/ml, 50 μg/ml and 100 μg/ml. The solution was incubated at room temperature for 30 min and analyzed spectrometrically at 517 nm. DPPH radical scavenging activity was calculated as percent inhibition. IC50 determined 50% inhibition of DPPH radical formation and capacity of DPPH radical scavenging activity was determined compared with vitamin C as standard antioxidant.

Radical scavenging activity=AblankAsampleAblank×100

where Ablank and Asample were absorbance data of control and sample, respectively.

Ferric reducing antioxidant power (FRAP)

Reducing scavenging activity was observed using FRAP method according to Amarowicz.24 Briefly, extracts were mixed with frap reagent containing 300 mM acetate buffer,10 mM TPTZ and 20 mM ferric chloride, and incubated at 37°C for 30 min in the dark condition. Ferrous tripyridyltriazine product were measured using spectrophotometer at 593 nm. FRAP value was expressed as mmol ferrous sulfate equivalent/g of sample dried weight.

Isolation of LDL

Process of human LDL isolation was approved by Mahasarakham University Ethics committee. LDL was isolated using floating sequential ultracentrifugation method, described previously.25 Briefly, LDL was isolated from fresh plasma of fasting overnight, healthy volunteers. Fresh plasma containing 4 mM EDTA and 1 mM phenylmethanesulfonyl fluoride (PMSF) as serine protease inhibitor. Adjusted density of plasma is 1.21 g/ml with solid potassium bromide (KBr). High density plasma was loaded to the lower part of ultracentrifuge tube, which was overlaid by gradient salt solutions, 1.063, 1.019 and 1.005 g/ml, respectively. LDL was isolated by ultracentrifugation at 286,000 g at 4°C for 24 h. The yellowish LDL fraction was collected between 1.019-1.063 g/ml densities and dialyzed using phosphate buffer saline (pH 7.38-7.42) with nitrogen flow at 4°C for 24 h. LDL was filtered through 0.22μm pore size membrane and then measured using bicinchoninic acid (BCA) assay.26

Assessment of lipid peroxidation
Thiobarbituric reactive substance (TBARs)

Malondialdehyde (MDA) is indicated as a product of lipid. MDA level was determined based on the reaction with thiobarbituric acid (TBA).27 The reaction was divided into two parts; the preliminary part was divided into three groups, no treated, LDL-Cu2SO4 co-incubation and pretreated of L. leucocephala and LDL prior to the incubation with Cu2SO4. The experiment part was the observation of anti-lipidperoxidation activity in HUVC. The assessment of lipid peroxidation activity was determined by incubation of the mixture with trichloroacetic acid (TCA) and thiobarbituric acid (TBA) in an acidic pH condition at 90°C for 20 min. The reaction was precipitated by centrifucation at 4,000g for 10 min at 4°C. MDA level was read using UV spectrophotometer at 532 nm. TBARs value was calculated using 1, 1, 3, 3-tetraethoxypropane as MDA standard curve.

Conjugated diene formation

Conjugated diene developed in LDL through oxidation of poly-unsaturated fatty acids (PUFAs) was observed. One milligram protein of LDL was incubated with 0.01 mg/ml L. leucocephala solution for 1 h at room temperature. oxLDL was induced using 10 μM Cu2SO4. Kinetic of LDL oxidation was monitored the changes of conjugated diene at the absorbance of 234 nM as described previously.28 The absorbance curve was comprised of three phases; lag phase, propagation phase and decomposition phase. Initial stage of LDL oxidation is lag phase time in which oxidant primary interacted with LDL. Prolong of lag phase time was referred to antioxidant activity of LDL. Lastly, decomposition phase is where LDL is completely oxidized, and OD value is stable.

HUVCs cultured

Endothelial cells function, and antioxidant capacity of vascular cells were determined in HUVC system. The process was approved by Mahasarakham University Ethics Committee. Umbilical veins were dissected from human umbilical cord of normal labor. Umbilical cord was processed within 2 h after vaginal delivery. With some modifications, umbilical veins were cultured according to Friedman R et al.29 Briefly, umbilical veins were dissected into ring with range 3-4 millimeters under strictly sterile technique and the rings are placed in 24 well plate cultured containing 2 ml of RPMI 1640 culture media (GIBCO®) supplemented with 10% FCS with 100 μg/ml gentamycin and 10 μg/ml ampicillin. Cultures were maintained at 37°C in 5% CO2 incubator with 95% O2 flow for four days. Oxidative stress was induced in HUVCs using different concentration of glucoses (7, 14, 50 mM) and/or 40 μg/ml oxLDL in each group. Concentration 0.1, 0.5 and 1 mg/mL of L. leucocephala were subsequently incubated in the culture for two days. HUVCs were rinsed with phosphate buffer saline (PBS) pH 7.37-7.47 before determination of SOD activity and NO level of vascular cells.

Real-time measurement of NO production

Real time production of NO in vascular endothelial cells was monitored using model inNO-T, NO measuring system with an amiNO-700 probe (Innovative Instruments, Inc., Tampa, FL), based on direct oxidation of NO to nitrite.30,31 Briefly, microelectrode probe was calibrated with calibration solution (1M H2SO4, 20 mg KI and 18 ml of ddH2O) prior to use. Picoamparer (pA) was adjusted to zero and calibrated by adding nitrite at different concentrations as following; 25 nM, 50 nM, 100 nM, 150 nM, and 200 nM. NO concentration was reported in nM.

SOD activity

SOD, an important scavenging enzyme for superoxide anion (O2•-), was determined for its activity using xanthine oxidase method. HUVCs were homogenized and ultracentrifuged at 12,000 g for 15 min. Aqueous of homogenate was aspirated and determined SOD activity using SOD determination kit (Fluka). The solutions and standard tube were mixed and incubated at 37°C for 20 min. SOD activity was determined spectrophotometrically at 450 nm. Calculated of SOD activity was showed in percent inhibition of O2•- production as the equation and reported in U/ml/mg tissue.

Morphology in HUVCs

HUVCs were sectioned according to embedding paraffin method.32 Briefly, the tissue was fixed, dehydrated and embedded in paraffin. The paraffin embedded tissue was then sectioned and deparafinized on a slide, followed by staining process using hematoxylin and eosin. The morphological changes were observed under light microscope.

Statistical analysis

All variables were summarized using means and standard deviations (SD). Statistical analysis was carried out to compare between groups by Kruskal-Wallis tests, and followed by Dunn’s method for multiple comparison. Statistical significant was consider when p-value is less than 0.05. (R 3.4.0).

RESULTS

Antioxidant contents

TPC and TFC contents was measured using the Folin–Ciocalteu method and aluminum chloride colorimetric method, respectively. The results showed that total phenolic of leaves dry weight of L. leucocephala at 1 g was found 51.04 ± 0.91 mg GAE/g. Whereas, TFC was showed 0.13 ± 0.01 mg catechin/g.

Antioxidant and anti-lipid peroxidation activity of L. leucocephala

Antioxidant activities were determined by using DPPH and FRAP methods. IC50 concentration of leave extract measured by DPPH method was 369.6 μg/ml, that is 576.79 μ 16.08 μg of vitamin C equivalent/mg of leave extract. The reducing power activity using FRAP method exhibited dried extract at 428.54 ± 15.32 mM FeII equivalent/g.

Anti-lipid peroxidation activity of L. leucocephala was observed in Cu2SO4-induced diene formation in isolated LDL. The result showed lag phase time was slightly longer in 0.1 mg/ml of L. leucocephala treated condition, in contrast with 44 ± 3.3% approximately lower of MDA concentration Table 1.

Effect of L. leucocephala on vascular cell of Human
Umbilical Vein Cultured
NO concentration

Influence of L. leucocephala in NO production was conducted under model in NO-T with amino-700 probe. The experiments were observed in HUVC-induced pre-obese condition using 40 μg/ml oxLDL and 7 nM glucose. Compared with positive control (without L. leucocephala), the result showed that NO concentration was significantly reduced when leave extracts at concentration of 0.05, 0.5 and 1 mg/mL were added Figure 1. However, only the leave extract at concentration of 0.1 mg/mL significantly increase NO level (p < 0.05).

Superoxide dismutase (SOD) activity

Scavenging of O2•- by SOD enzyme was performed using SOD determination kits-WST (Dojindo) and displayed in percent inhibition of O2•- production Figure 2. The experiments were demonstrated using pre-obese condition. Adding 0.1 mg/ml of L. leucocephala, SOD activity was significantly increased compared with control and positive control (p < 0.005 and p < 0.05, respectively). In contrast, 0.5 and 1 μg/ml of leave extracts significantly reduced SOD activity compared with both control (p < 0.001 and p < 0.005, respectively) and positive control (p < 0.005).

Assessment of lipid peroxidation

Figure 3 have shown MDA concentration (mmol/mg), an indicator for lipid peroxidation. The experiment was performed using TBAR assay to indicate level of MDA in the pre-obese induced system. The result showed that only L. leucocephala at concentration 0.05 mg/ml can maintain level of lipid peroxidation compared with control group. When leave extract concentration was increased, the result also exhibited the dose response relationship of the extract and MDA concentration Figure 3.

Morphology of HUVCs

Morphology of HUVCs were observed under 20x light microscope Figure 4. The result showed migration of smooth muscle cells in LDL and glucose induced oxidative stress comparing with control group Figure 4A and 4B. Moreover, intact of vascular cell was clearly reduced, in parallel with death of vascular smooth muscle cells and endothelial cells. In contrast, 0.05 mg/ml of L. leucocephala treated with LDL and glucose induced oxidative stress showed similarity of HUVCs morphology compared with control Figure 4A and 4C. When concentration of extract was increased, at dose 0.1 mg/ml leave extract resulted in increase of smooth muscle cells density and migration Figure 4D. Interestingly, at dose 0.5 and 1 mg/ml leave extracts, the results showed obviously reduction in vascular cells and change in nucleus morphology Figure 4E and 4F.

Table 1

Effect of L. leucocephala in LDL oxidation. Lag phase is determined in the initial step of diene formation curve.

 Lag phase time (minutes)MDA (nmol/mg LDL protein)
LDL>90-12010.5 ± 0.62
LDL + 10 μm Cu2SO438-7029.35 ± 2.62
LDL + 10 μm Cu2SO4 + 0.1mg/ml LL65-8523.45± 1.69

Note: LDL oxidation was determined of final concentration at 0.1 mg/ml of L. leucocephala (LL) (n =5). Data were express as Mean ± SD.

Figure 1

NO concentration under pre-obese induced condition. *Significantly different from control group (* p<0.05), (** p<0.01), (*** p<0.005). #Significantly different from positive control group (# p<0.05), (## p<0.01), (### p<0.005). OxLDL indicated for oxidized LDL. LL indicated for Leucaena leucocephala.

https://s3-us-west-2.amazonaws.com/jourdata/pj/PharmacognJ-10-148-g001.jpg
Figure 2

Level of SOD activity reported as percent inhibition of superoxide anion production in pre-obese induced condition. *Significantly different from control group (* p<0.05), (** p<0.01), (*** p<0.005). #Significantly different from positive control group (# p<0.05), (## p<0.01), (### p<0.005). OxLDL indicated for oxidized LDL. LL indicated for Leucaena leucocephala.

https://s3-us-west-2.amazonaws.com/jourdata/pj/PharmacognJ-10-148-g002.jpg

Conclusion and discussion

Impaired fasting blood glucose is caused by increasing of glucose concentration in fasting state, but the patients with IFG have not already develop diabetes mellitus. Those with IFG might eventually develop CVS by glucose inducing oxidative stress production.1 Thus, to promote reduction of oxidative stress, this study aims to observe antioxidant activity of L. leucocephala in endothelium function using impair fasting glucose in human umbilical vein cultured (HUVCs) model.

Total phenolic and flavonoid contents was determined, and the result showed 51.04 ± 0.91 mgGAE/g and 0.13 ± 0.01 mg of catechin/g content in dry leave extract, respectively. Likewise, other studies that found phenolic at 3.21 mg GAE/g,33 37.38 ± 0.49 mg GAE/g,17 78.8 g GAE/100g extract,18 258.4±7.45 mg GAE/g,16 7.51 to 12.06 mg GAE/g,34 and flavonoid contents at 159.61±12.79 mg QE/g (Quercetin equivalent),16 2.80 to 3.59 mg QE/g34 depended on parts of plant collection and solution extracted. This compon ents suggest antioxidant activities of L. leucocephala, as confirmed in Table 1. The preliminary study indicated that L. leucocephala provides antioxidant activity using DPPH method resulting in 50% scavenging activity at 369.6 μg/ml, which is equivalent to 576.79 ± 16.08 μg of vitamin C equivalent/mg. The result was confirmed by FRAP method showing the reducing power activity of dried extract at 428.54 ±15.32 mM FeII equivalent/g. This result showed higher scavenging activity comparing to previous study 16 that observing the activity in seed extract 17,18, suggested leave extract might provide greater scavenging activity compared with the seed part.

Figure 3

Concentration of MDA, an indicator of lipid peroxidation, in pre-obese induced condition. *Significantly different from control group (* p<0.05), (** p<0.01), (*** p<0.005). #Significantly different from positive control group (# p<0.05), (## p<0.01), (### p<0.005). OxLDL indicated for oxidized LDL. LL indicated for Leucaena leucocephala.

https://s3-us-west-2.amazonaws.com/jourdata/pj/PharmacognJ-10-148-g003.jpg
Figure 4

Morphological changes in HUVC. A, control group. B, LDL and glucose induced oxidative stress in HUVC. C, 0.05 mg/ml of L. leucocephala treated with LDL and glucose induced oxidative stress in HUVCs. D, 0.1 mg/ml of L. leucocephala treated with LDL and glucose induced oxidative stress in HUVCs. E, 0.5 mg/ml of L. leucocephala treated with LDL and glucose induced oxidative stress in HUVCs. F, 1 mg/ml of L. leucocephala treated with LDL and glucose induced oxidative stress in HUVCs.

https://s3-us-west-2.amazonaws.com/jourdata/pj/PharmacognJ-10-148-g004.jpg

The effects of L. leucocephala on HUVCs metabolites were shown in Figure 1 to 4, despite on each category. Figure 1 showed NO production in L. leucocephala preincubated HUVCs. The result shown that L. leucocephala significantly influenced NO production in HUVC-induced pre-obese condition at the concentration of 0.1 mg/mL, but maintained its level at 0.05 mg/mL. On the other hand, result in Figure 2 showed that induction of SOD activity was gradually increased in parallel with concentrations of leave extract (0.05 and 0.1 mg/mL), before significantly decreasing at dose 0.5 and 1 mg/mL. The alteration of HUVCs activity in high dose of leave extracts might suggest the death of those vascular cells as observed in Figure 4. In assessment of lipid peroxidation activity in HUVCs, MDA concentration, an indicator of lipid peroxidation, was determined in Figure 3. The result showed decreasing of MDA level in 0.05 mg/mL L. leucocephala treated group, and gradually in dose response concentration in L. leucocephala concentration of 0.1, 0.5 and 1 mg/mL, respectively. These results were verified in culture of HUVCs Figure 4. With histology of vascular cells, the result showed that the vascular cells were obviously dead in HUVC-induced pre-obese condition.

In this condition of increasing extracellular glucose, it was suggested to induce endothelial cell dysfunction by increased activation of NADPH oxidase and IL1β,35,36,37 which might eventually lead to senescence of the cells. When 0.05 mg/mL of leave extracts were pre-incubated in the system, the overall of vascular cells have been found resembling the control group. It suggested the healthy condition of HUVCs as L. leucocephala has been found to provide the activity to reduce blood glucose level in diabetic rats 17 by increasing of glucose uptake into cells.38 In comparison with L. leucocephala at concentration of 0.1 mg/mL, smooth muscle cells migration was observed in Figure 4C, suggested this dose may performed the activity of pro-oxidant agent by activating NAPPH oxidase, induces inducible nitric oxide synthase (iNOS) activity of vascular smooth muscle cell.39 In addition, ROS may also act as vascular endothelial growth factor (VEGF) which induces vascular cells migration and proliferation.40 With the production of NO, it can interact with superoxide anions (O2·-) and results in peroxynitrite production, which is a radical that can induce endothelial dysfunction and damage cells.19,41 Although no cell death have been observed. This condition may explain the increasing in NO level and SOD activity Figure 1 and Figure 2, respectively as for the oxidation process have been introduced. The MDA level in Figure 3 also confirmed this probability as the lipid peroxidation was slightly increased.

At the higher concentration of L. leucocephala, the result of both NO level and SOD activity were significantly decreased Figure 1 and 2, respectively. These events may suggest endothelial cell dysfunction and damage, because of mimosine, a toxic component of L. leucocephala.42,43,44 With this result, it is suggested that this toxic activity may be applied to the inhibitory effect on proliferation of cancer.45

In conclusion, this study has been performed to exhibit the antioxidant activity of L. leucocephala in endothelium functions and has been found to have an appropriate concentration at 0.05 and 0.1 mg/mL in reducing oxidative stress condition in impaired fasting blood glucose patients. The higher doses of leave extracts may introduce the toxic effect to endothelial cells, which may contribute to a plausible way to inhibit angiogenesis of cancer cell. Nevertheless, the optimal level for toxic activity in inhibition of cancer angeiogenesis should be further investigated. As well as the underlying mechanism of how L. leucocephala affects in oxidative stress in condition of having impaired fasting glucose has been performed should be further validated.

GRAPHICAL ABSTRACT

https://s3-us-west-2.amazonaws.com/jourdata/pj/PharmacognJ-10-148-g005.jpg

ACKNOWLEDGEMENT

This study was funded by Faculty of Medicine, Mahasarakham University.

ABOUT AUTHORS

https://s3-us-west-2.amazonaws.com/jourdata/pj/PharmacognJ-10-148-g006.jpg

Ratikorn Chatchanayuenyong: Biomedical Department, Faculty of Medicine, Mahasarakham University, Mahasarakham, THAILAND.

Notes

[2] Conflicts of interest CONFLICTS OF INTEREST The authors declare that there is no conflict of interest regarding the publication of this article.

ABBREVIATION USED

LL

Leucaena leucocephala

LDL

low-density lipoprotein

oxLDL

oxidized low-density lipoprotein

HUVCs

human umbilical vein cultured

SOD

superoxide anion

NO

nitric oxide

GAE

gallic equivalent

DW

dried weight

DPPH

1,1-diphenyl-2 picryhydrazyl

MDA

malondialdehyde

IFG

impaired fasting glucose

ROS

reactive oxygen species

CVS

cardiovascular diseases

NCDs

noncommunicable diseases

TPC

total phenolic content

TFC

total flavonoid content

FRAP

ferric reducing antioxidant power

TBAR

thiobarbituric acid reactive substance

BCA

bicinchoninic acid

TCA

trichloroacetic acid

TBA

thiobarbituric acid

PUEAs

polyunsaturated fatty acid

PBS

phosphate buffer saline

REFERENCES

1. 

Shaw JE, Zimmet PZ, Courten M, Dowse GK, Chitson P, Gareeboo H, et al. , authors. Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? Diabetes Care. 1999;22(3):399–402

2. 

Ceriello A, Motz E , authors. Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes, and Cardiovascular Disease? The Common Soil Hypothesis Revisited. Arteriosclerosis Thrombosis Vascular Biol. 2004;24(5):816–23

3. 

Wright E, Scism-Bacon JL, Glass LC , authors. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Inter J Clinical Practice. 2006;60(3):308–14

4. 

Ghebre YT, Yakubov E, Wong WT, Krishnamurthy P, Sayed N, Sikora AG, et al. , authors. Vascular Aging: Implications for Cardiovascular Disease and Therapy. Translational Med Sunnyvale Calif [Internet]. 2016. 6(4)cited 2017 Oct 9Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602592/.

5. 

Simó R, Ballarini S, Cunha-Vaz J, Ji L, Haller H, Zimmet P, et al. , authors. Non-Traditional Systemic Treatments for Diabetic Retinopathy: An Evidence-Based Review. Current Med Chem. 2015;22(21):2580–9

6. 

Reho JJ, Rahmouni K , authors. Oxidative and inflammatory signals in obesity-associated vascular abnormalities. Clinical Sci. 2017;131(14):1689–700

7. 

Virdis A , author. Endothelial Dysfunction in Obesity: Role of Inflammation. High Blood Press Cardiovasc Prevention Off. J Ital Society Hypertension. 2016;23(8):83–5

8. 

Infante T, Forte E, Aiello M, Salvatore M, Cavaliere C , authors. in vivo and in vitro Analysis in Coronary Artery Disease Related to Type 2 Diabetes. Front Endocrinol [Internet]. 2017. 8:Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566996/.

9. 

Bourgoin F, Bachelard H, Badeau M, Mélançon S, Pitre M, Larivière R, et al. , authors. Endothelial and vascular dysfunctions and insulin resistance in rats fed a high-fat, high-sucrose diet. Am J Physiology Heart Circulatory Physiol. 2008;295(3):H1044–55

10. 

Bruno RM, Penno G, Daniele G, Pucci L, Lucchesi D, Stea F, et al. , authors. Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction. Diabetologia. 2012;55(6):1847–55

11. 

Shen K-P, Lin H-L, Chang W-T, Lin J-C, An L-M, Chen I-J, et al. , authors. Eugenosedin-A ameliorates hyperlipidemia-induced vascular endothelial dysfunction via inhibition of α1-adrenoceptor/5-HT activity and NADPH oxidase expression. Kaohsiung J Med Sci. 2014;30(3):116–24

12. 

Gradinaru D, Borsa C, Ionescu C, Prada GI , authors. Oxidized LDL and NO synthesis-- Biomarkers of endothelial dysfunction and ageing. Mech Ageing Dev. 2015;151:101–13

13. 

Meisinger C, Baumert J, Khuseyinova N, Loewel H, Koenig W , authors. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation. 2005;112(5):651–7

14. 

Walter MF, Jacob RF, Jeffers B, Ghadanfar MM, Preston GM, Buch J, et al. , authors. Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study. J Am Coll Cardiology. 2004;44(10):1996–2002

15. 

Hassan RA, Tawfik WA, Abou-Setta LM , authors. The flavonoid constituents of Leucaena leucocephala. Growing in Egypt, and their biological activity. African J Traditional, Complement Alternative Med AJTCAM. 2014;11(1):67–72

16. 

Dzoyem JP, Eloff JN , authors. Anti-inflammatory, anticholinesterase and antioxidant activity of leaf extracts of twelve plants used traditionally to alleviate pain and inflammation in South Africa. J Ethnopharmacology. 2015;160:194–201

17. 

Chowtivannakul P, Srichaikul B, Talubmook C , authors. Antidiabetic and antioxidant activities of seed extract from Leucaena leucocephala (Lam.) de Wit. Agric Nat Resources. 2016;50(5):357–61

18. 

Benjakul S, Kittiphattanabawon P, Sumpavapol P, Maqsood S , authors. Antioxidant activities of lead (Leucaena leucocephala) seed as affected by extraction solvent, prior dechlorophyllisation and drying methods. J Food Sci Technol. 2014;51(11):3026–37

19. 

Pitocco D, Zaccardi F, Di Stasio E, Romitelli F, Santini SA, Zuppi C, et al. , authors. Oxidative stress, nitric oxide, and diabetes. Rev Diabetic Stud RDS. 2010;7(1):15–25

20. 

Cai H, Harrison DG , authors. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circulation Res. 2000;87(10):840–4

21. 

khatoon M, Islam E, Islam R, Rahman AA, Alam AK, Khondkar P, et al. , authors. Estimation of total phenol and in vitro antioxidant activity of Albizia procera leaves. Bio Med Central Res Notes. 2013;6(1):121

22. 

Zhishen J, Mengcheng T, Jianming W , authors. The determination of flavonoid contents in mulberry and their scavenging effects on superoxide radicals. Food Chem. 1999;64(4):555–9

23. 

Deng J, Cheng W, Yang G , authors. A novel antioxidant activity index (AAU) for natural products using the DPPH assay. Food Chem. 2011;125(4):1430–5

24. 

Amarowicz R, Naczk M, Shahidi F , authors. Antioxidant activity of various fractions of non-tannin phenolics of canola hulls. J Agric Food Chem. 2000;48(7):2755–9

25. 

Schumaker VN, Puppione DL , authors. [6] Sequential flotation ultracentrifugation. Methods Enzymology. 1986;128:155–70

26. 

Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al. , authors. Measurement of protein using bicinchoninic acid. Anal Biochemistry. 1985;150(1):76–85

27. 

Olszewska-Słonina DM, Matewski D, Czajkowski R, Olszewski KJ, WoŸniak A, Odrowaz-Sypniewska G, et al. , authors. The concentration of thiobarbituric acid reactive substances (TBARS) and paraoxonase activity in blood of patients with osteoarthrosis after endoprosthesis implantation. Med Sci Monitor Inter Med J Experimental Clinical Res. 2011;17(9):CR498–CR504

28. 

Esterbauer H, Gebicki J, Puhl H, Jürgens G , authors. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radical Biology Med. 1992;13(4):341–90

29. 

Friedman R, Betancur M, Boissel L, Tuncer H, Cetrulo C, Klingemann H , authors. Umbilical Cord Mesenchymal Stem Cells: Adjuvants for Human Cell Transplantation. Biology Blood Marrow Transplant. 2007;13(12):1477–86

30. 

Shibuki K , author. An electrochemical microprobe for detecting nitric oxide release in brain tissue. Neuroscience Res. 1990;9(1):69–76

31. 

Christodoulou D, Kudo S, Cook JA, Krishna MC, Miles A, Grisham MB, et al. , authors. Electrochemical methods for detection of nitric oxide. Methods Enzymology. 1996;268:69–83

32. 

Hewitt SM, Lewis FA, Cao Y, Conrad RC, Cronin M, Danenberg KD, et al. , authors. Tissue Handling and Specimen Preparation in Surgical Pathology: Issues Concerning the Recovery of Nucleic Acids from Formalin-Fixed, Paraffin-Embedded Tissue. Arch Pathology Lab Med. 2008;132(12):1929–35

33. 

Zarin MA, Wan HY, Isha A, Armania N , authors. Antioxidant, antimicrobial and cytotoxic potential of condensed tannins from Leucaena leucocephala hybrid-Rendang. Food Sci Hum Wellness. 2016;5(2):65–75

34. 

Sharma P, Chaurasia S , authors. Evaluation of Total Phenolic, Flavonoid Contents and Antioxidant Activity of Acokanthera oppositifolia and Leucaena leucocephala. International Journal of Pharmacognosy and Phytochemical Research. 2015;7:175–80

35. 

Peiró C, Romacho T, Azcutia V, Villalobos L, Fernández E, Bolaños JP, et al. , authors. Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway. Cardiovasc Diabetology. 2016;15:1:82

36. 

Lafuente N, Matesanz N, Azcutia V, Romacho T, Nevado J, Rodríguez-Mañas L, et al. , authors. The deleterious effect of high concentrations of D-glucose requires pro-inflammatory preconditioning. J Hypertension. 2008;26(3):478–85

37. 

Vallejo S, Palacios E, Romacho T, Villalobos L, Peiró C, Sánchez-Ferrer CF , authors. The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats. Cardiovasc Diabetology. 2014;13(1):158

38. 

Kuppusamy UR, Arumugam B, Azaman N, Jen Wai C , authors. Leucaena leucocephala Fruit Aqueous Extract Stimulates Adipogenesis, Lipolysis, and Glucose Uptake in Primary Rat Adipocytes. Sci World J [Internet]. 2014 [cited 2017 Oct 2];2014Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142670/.

39. 

MacNaul KL, Hutchinson NI , authors. Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. Biochemical Biophysical Res Communications. 1993;196(3):1330–4

40. 

Kuroki M, Voest EE, Amano S, Beerepoot LV, Takashima S, Tolentino M, et al. , authors. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clinical Invest. 1996;98(7):1667–75

41. 

Moreira JD, Pernomian L, Gomes MS, Moreira RP, Prado AF, Silva CHTP, et al. , authors. Enhanced nitric oxide generation from nitric oxide synthases as the cause of increased peroxynitrite formation during acute restraint stress: Effects on carotid responsiveness to angiotensinergic stimuli in type-1 diabetic rats. Euro J Pharmacology. 2016;783:11–22

42. 

Chou CH, Kuo YL , authors. Allelopathic research of subtropical vegetation in Taiwan: III. Allelopathic exclusion of understory by Leucaena leucocephala (Lam.) de Wit. J Chemical Ecol. 1986;12(6):1431–48

43. 

Murakoshi I, Ikegami F, Hinuma Y, Hanma Y , authors. Purification and characterization of L-mimosine synthase from Leucaena leucocephala. Phytochemistry. 1984;23(9):1905–8

44. 

Ilham Z, Hamidon H, Rosji NA, Ramli N, Osman N , authors. Extraction and Quantification of Toxic Compound Mimosine from Leucaena leucocephala Leaves. Procedia Chem. 2015;16:164–70

45. 

Dong Z, Zhang J-T , authors. EIF3 p170, a Mediator of Mimosine Effect on Protein Synthesis and Cell Cycle Progression. Molecular Biology of the Cell. 2003;14(9):3942–51